Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Salivary hypersecretion
ADR ID BADD_A03914
ADR Hierarchy
07      Gastrointestinal disorders
07.06      Salivary gland conditions
07.06.01      Oral dryness and saliva altered
07.06.01.009      Salivary hypersecretion
Description Increased salivary flow. [MeSH]
MedDRA Code 10039424
MeSH ID D012798; D012472
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hypersalivation | Increased salivation | Ptyalism | Saliva increased | Saliva secretion excessive | Saliva secretion increased | Salivary hypersecretion | Salivation | Sialorrhoea | Sialorrhea | Hypersialosis | Drooling
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02267Trazodone hydrochloride--
BADD_D02303Tropicamide0.011010%
BADD_D02307Trovafloxacin--
BADD_D02308Trovafloxacin mesylate--
BADD_D02329Valproic acid0.000443%
BADD_D02337Varenicline--
BADD_D02346Venlafaxine--
BADD_D02355Vigabatrin0.000507%
BADD_D02373Warfarin--
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02393Zolmitriptan--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02397Zopiclone--
BADD_D02398Zuclopenthixol--
BADD_D02432Glycopyrronium0.004563%
BADD_D02433Salbutamol0.000026%
BADD_D02442Magnesium oxide0.000584%
BADD_D02445Solifenacin0.000772%
BADD_D02451Pimavanserin0.001204%
BADD_D02464Fingolimod--
BADD_D02468Cannabidiol0.000338%
BADD_D02491Valbenazine0.016993%
BADD_D02510Rucaparib0.000533%
BADD_D02522Lithium citrate-
The 9th Page    First    Pre   9    Total 9 Pages